Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
61.56
+1.56 (2.60%)
At close: Oct 21, 2026, 4:00 PM EDT
62.64
+1.08 (1.75%)
After-hours: Oct 21, 2026, 5:08 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $3.01 billion as of October 21, 2026. It is the 5,255th most valuable company in the world and the 1,511th biggest in the United States. Its market cap has increased by 0.59% in one year.
Market Cap
3.01B
Enterprise Value
3.01B
1-Year Change
0.59%
Global Rank
Country Rank
#1,511 United States
Category
ChartMarket Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $3.01B, an increase of 2,149.63%. That is a compound annual growth rate of 40.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 3.01B | -34.73% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IDEAYA Biosciences | 3.43B |
| Tarsus Pharmaceuticals | 3.13B |
| Viking Therapeutics | 3.11B |
| Telix Pharmaceuticals | 3.11B |
| Enliven Therapeutics | 3.10B |
| Disc Medicine | 3.01B |
| Dyne Therapeutics | 3.01B |
| Denali Therapeutics | 2.99B |